In case you missed it: April 25 to April 29
A look back at the week's news.
This week's top headlines:
FDA warn public of risks, false results with noninvasive prenatal screening tests
The FDA recently issued a statement warning the public of the risks and potential false results obtained with noninvasive prenatal screening tests, noting that inappropriate usage and interpretation has resulted in improper medical decisions.
Coronavirus Omicron variant, vaccine, and case numbers in the United States: April 28, 2022
Omicron by the numbers.
Women’s health in review: April 2022
A look back at this month’s most popular stories, according to you.
Rotating shift work and onset of menopause
A Canadian study in Menopause suggests shift work may increase women's likelihood to experience delayed onset of menopause.
Prescription spending rose 12% in 2021
A report that tracks the use of medicines in the United States shows that spending on prescriptions rose 12% in 2021 primarily due to COVID-19 vaccines and therapies.
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
IUD placement within 48 hours nonsuperior vs 2 to 4 weeks after abortion
November 19th 2024A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.
Read More
